Skip to content

David Morgan

3 papers in the library · 16 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

The impact of antidepressant use on MDMA fatalities: A matched case-control study using a post-mortem database.

Journal of psychopharmacology (Oxford, England) April 6, 2026 Kirsten L Rock, Paul Rees, David Morgan et al.

3,4-methylenedioxymethamphetamine (MDMA) is being investigated as a new therapy for post-traumatic stress disorder (PTSD). With antidepressants as the first-line pharmacotherapy for PTSD, it is important to understand any drug-drug interactions between antidepressants and MDMA. This study aimed to investigate the association between antidepressant use and MDMA fatality using a drug-death...

Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study

International Journal of Multiple Research Approaches April 30, 2025 Kim Hoffman, Todd P. Korthuis, Kellie Pertl et al. 2 citations

Most Delphi studies primarily rely on questionnaires and subsequent quantitative ratings across multiple rounds to learn about a complex issue. This article demonstrates the integration of qualitative inquiry into a Delphi study to enhance and complement quantitative findings. We conducted a mixed methods Delphi study to establish a comprehensive list of quality and safety indicators for best...

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study

Journal of Psychopharmacology June 18, 2024 Kim Hoffman, Alissa Bazinet, Kellie Pertl et al. 14 citations

Background: Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes. Aims: To develop core measures of best practices. Methods: A three-phase e-Delphi process recruited 36 experts with 5 or more years’ experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings,...